Ameriprise
RXDX

Ameriprise’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Ameriprise’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,910
Closed -$312K – 4031
2023
Q1 		$312K Buy
2,910
+165
+6% +$17.7K ﹤0.01% 3599
2022
Q4 		$302K Buy
+2,745
New +$302K ﹤0.01% 3582